近日,默沙东和GSK也公布了上半年的财报。GSK :肿瘤业务收入大涨,HIV业务保持强势7月30日,GSK公布2025上半年业绩,总营收155.02亿英镑(约201.57亿美元),同比增长5%(按固定汇率CER计算)。GSK主营业务主要分为专科药物、疫苗以及普药三大板块。HIV业务继续保持强劲增长势头,收入达到35.94亿英镑(约46.73亿美元),同比增长10%。口服复方制剂Dovato(多...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.